{
    "Case ID": "020897",
    "Crime_Name": [
        "Patent Infringement Dispute"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [
        "Patent Infringement Dispute"
    ],
    "Legal_Issue": [
        "Whether Sanofi is liable to Apotex for losses due to delayed market entry of generic ramipril under Section 8 of the PM (NOC) Regulations"
    ],
    "Governing_Law": [
        "Section 8 of the Patented Medicines (Notice of Compliance) Regulations (PM (NOC) Regulations)"
    ],
    "Procedural_Stage": [
        "Trial"
    ],
    "Evidence_Assessment": [
        "Expert testimonies on market dynamics, pricing, and regulatory impacts"
    ],
    "Decision_Outcome": [
        "Sanofi is liable to compensate Apotex for lost profits during the Relevant Period"
    ],
    "Burden_of_Proof": [
        "On Apotex to demonstrate entitlement to damages under Section 8"
    ],
    "Credibility_Factor": [
        "Court relied on expert evidence to construct hypothetical market scenario"
    ],
    "Legal_Rule": [
        "Section 8 allows a second person to claim damages if a prohibition application by the first person fails and causes market delay"
    ],
    "Standard_of_Review": [
        "Reasonableness and correctness in interpretation of regulatory provisions"
    ],
    "Procedural_Issue": [
        "Calculation of damages and determination of relevant market period"
    ],
    "Grounds_for_Claim": [
        "Delayed market entry caused by unsuccessful prohibition application by Sanofi"
    ],
    "Outcome_on_Merits": [
        "Apotex succeeded on the merits; Sanofi found liable"
    ],
    "Decision_Maker": [
        "Trial Court"
    ],
    "Judicial_Review_Outcome": [],
    "Review_Standard": [],
    "Procedural_Fairness_Assessment": [
        "Fair trial with opportunity for both parties to present evidence and legal arguments"
    ],
    "Key_Evidence_Considered": [
        "Market share estimates, entry dates of authorized generics, pricing data, trade spend, API costs"
    ],
    "Legal_Framework": [
        "PM (NOC) Regulations, Canadian patent law"
    ],
    "Applicant_Challenge": [
        "Sanofi's prohibition application under PM (NOC) Regulations"
    ],
    "Court_Result": [
        "Sanofi ordered to calculate and pay damages to Apotex based on court guidelines"
    ],
    "Legal_Rule_Source": [
        "Regulatory provision: Section 8 of PM (NOC) Regulations"
    ],
    "Standard_of_Proof": [
        "Balance of probabilities"
    ],
    "Defendant_Response": [
        "Sanofi contested liability and challenged damage calculations"
    ],
    "Evidence_Type": [
        "Expert testimony, market data, regulatory timelines"
    ],
    "Remedy_Requested": [
        "Damages for lost profits due to delayed market entry"
    ],
    "Outcome": [
        "Damages awarded; Sanofi required to pay compensation"
    ],
    "Decision_Authority": [
        "Trial Court"
    ],
    "Remedy_Sought": [
        "Monetary compensation under Section 8"
    ],
    "Resolution_Mechanism": [
        "Judicial trial and determination"
    ],
    "Legal_Provision": [
        "Section 8 of the PM (NOC) Regulations"
    ],
    "Authority": [
        "Canadian Federal Court or equivalent jurisdiction"
    ],
    "Claimant_Status": [
        "Second person (generic manufacturer) under PM (NOC) Regulations"
    ],
    "Legal_Provision_Cited": [
        "Section 8 of the PM (NOC) Regulations"
    ],
    "Grounds_for_Inadmissibility_or_Allegation": [
        "Allegation of unjustified delay in market entry due to failed prohibition"
    ],
    "Applicable_Process": [
        "Section 8 damages proceeding under PM (NOC) Regulations"
    ],
    "Outcome_of_Review": [],
    "Pending_Relief_or_Application": [],
    "Jurisdiction": [
        "Canada"
    ],
    "Governing_Rule": [
        "Section 8 of the PM (NOC) Regulations"
    ]
}